Earnings To Watch: Ardent Health Inc (ARDT) Reports Q3 2025 Result
This article first appeared on GuruFocus.
Ardent Health Inc (NYSE:ARDT) is set to release its Q3 2025 earnings on Nov 12, 2025. The consensus estimate for Q3 2025 revenue is $1.55 billion, and the earnings are expected to come in at $0.41 per share. The full year 2025's revenue is expected to be $6.35 billion and the earnings are expected to be $1.85 per share. More detailed estimate data can be found on the Forecast page.
Warning! GuruFocus has detected 2 Warning Sign with ARDT.
Is ARDT fairly valued? Test your thesis with our free DCF calculator.
Revenue estimates for Ardent Health Inc (NYSE:ARDT) have declined from $6.35 billion to $6.35 billion for the full year 2025 and declined from $6.66 billion to $6.66 billion for 2026 over the past 90 days. Earnings estimates for Ardent Health Inc (NYSE:ARDT) have declined from $1.86 per share to $1.85 per share for the full year 2025 and declined from $1.96 per share to $1.94 per share for 2026 over the past 90 days.
In the previous quarter of 2025-06-30, Ardent Health Inc's (NYSE:ARDT) actual revenue was $1.65 billion, which beat analysts' revenue expectations of $1.55 billion by 6.40%. Ardent Health Inc's (NYSE:ARDT) actual earnings were $0.52 per share, which beat analysts' earnings expectations of $0.39 per share by 32.32%. After releasing the results, Ardent Health Inc (NYSE:ARDT) was up by 6.10% in one day.
Based on the one-year price targets offered by 12 analysts, the average target price for Ardent Health Inc (NYSE:ARDT) is $19.42 with a high estimate of $23.00 and a low estimate of $12.00. The average target implies an upside of 42.14% from the current price of $13.66.
Based on GuruFocus estimates, the estimated GF Value for Ardent Health Inc (NYSE:ARDT) in one year is $0, suggesting a downside of -100% from the current price of $13.66.
Based on the consensus recommendation from 13 brokerage firms, Ardent Health Inc's (NYSE:ARDT) average brokerage recommendation is currently 2.1, indicating an \\"outperform\\" status. The rating scale ranges from 1 to 5, where 1 signifies strong buy, and 5 denotes sell.